Status:
ENROLLING_BY_INVITATION
5-SENSE Score Validation Study
Lead Sponsor:
Duke University
Collaborating Sponsors:
Christian Doppler University Hospital
Conditions:
Epilepsy Intractable
Eligibility:
All Genders
15+ years
Brief Summary
The purpose of this study is to assess how well a new scoring system called the 5-SENSE score can predict where seizures start in the brain using Stereoelectroencephalography (SEEG). The 5-SENSE Score...
Eligibility Criteria
Inclusion
- patients aged 15 years or older in whom no direct surgical approach can be offered and who are discussed in the multidisciplinary team discussion
- availability of complete non-invasive presurgical work-up (including high-resolution MRI according to the in-center epilepsy protocol, video-telemetry with the recording of a minimum of one habitual clinic and EEG seizure, available as original files for review)
Exclusion
- no telemetry/scalp EEG in center
- no protocol MRI in center
- subdural/GRID electrodes
Key Trial Info
Start Date :
January 9 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06138808
Start Date
January 9 2024
End Date
November 1 2025
Last Update
February 27 2025
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida College of Medicine
Gainesville, Florida, United States, 32610
2
Northwestern University
Chicago, Illinois, United States, 60611
3
Duke University Health System
Durham, North Carolina, United States, 27710
4
Presbyterian-Shadyside Hospital
Pittsburgh, Pennsylvania, United States, 15232